Loading
The United Arab Emirates' federal medicines regulator, set up in 2023. It approves and registers medicines and medical devices, oversees clinical trials and monitors drug safety.
The establishment's site says it was established on 29 September 2023 as the federal authority responsible for regulating medical and pharmaceutical products, including medical devices, blood derivative products and stem cells, and that its work covers research and development, clinical and non-clinical trials, pharmaceutical testing, drug approval and registration, manufacturing, market authorisation, pharmacovigilance, control and inspection. WHO's list of regulators operating at maturity level 3 or 4 (August 2026) does not include the UAE. The coordinates are an approximate Abu Dhabi city point.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/